EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification

Dana Ivancovsky-Wajcman, Elizabeth J Pekas, Leyla de Avila, Lynn H Gerber, Shira Zelber-Sagi

Clinics in Liver Disease · 2026-05 · 30 (2) · 359-379

DOI: 10.1016/j.cld.2026.01.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2026-05. Verfasst von Dana Ivancovsky-Wajcman und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Global NASH/MASH Council, Washington, DC, USA. Electronic address: danaivanc@gmail.com. Hauptthemen laut MEDLINE: Life Style, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Weight reduction (≥5% to improve steatosis and ≥7-10% to improve inflammation and fibrosis) through lifestyle modifications is a first-line treatment of metabolic dysfunction-associated steatotic liver disease. Although the Mediterranean diet is the most evidence-based and recommended diet, similar plant-based diets are also acceptable. Physical activity and exercise (aerobic and resistance) are effective in steatosis reduction, independent of weight loss. However, the uptake of lifestyle interventions is challenging, and to enhance adherence, clinicians, policymakers, and stakeholders should support individuals by increasing awareness and promoting a healthier environment. Behavioral support, personalization, and sustainability of recommendations are key factors in individualized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Life StyleNon-alcoholic Fatty Liver DiseaseFatty LiverHumansExerciseDiet, MediterraneanWeight LossRisk Reduction Behavior

Stichwörter der Autor:innen

DietExerciseLifestyleMASLD

Autor:innen und Institutionen

  • The Global NASH/MASH Council, Washington, DC, USA. Electronic address: danaivanc@gmail.com.
  • The Global NASH/MASH Council, Washington, DC, USA.
  • The Global NASH/MASH Council, Washington, DC, USA; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.

Zitieren

APA

Ivancovsky-Wajcman, D., Pekas, E. J., de Avila, L., Gerber, L. H., & Zelber-Sagi, S. (2026). Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification. Clinics in Liver Disease, 30(2), 359-379. https://doi.org/10.1016/j.cld.2026.01.002

Vancouver

Ivancovsky-Wajcman D, Pekas EJ, de Avila L, Gerber LH, Zelber-Sagi S. Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification. Clinics in Liver Disease. 2026;30(2):359-379. doi:10.1016/j.cld.2026.01.002

BibTeX
@article{IvancovskyWajcman2026,
  author = {Ivancovsky-Wajcman, Dana and Pekas, Elizabeth J and de Avila, Leyla and Gerber, Lynn H and Zelber-Sagi, Shira},
  title = {Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification},
  journal = {Clinics in Liver Disease},
  year = {2026},
  volume = {30},
  number = {2},
  pages = {359--379},
  doi = {10.1016/j.cld.2026.01.002}
}
Kostenlos starten →